Bullfrog AI Holdings, a company dealing in precision medicine, is raising funds on Funders USA. The company aims to use the artificial intelligence platform to predict which patients will benefit from medications, thereby improving clinical outcomes. The technology will also help in eliminating the trial and error approach in prescriptions. Vininder Singh founded Bullfrog AI Holdings in February 2020. The current round of crowdfunding has a minimum raise of $25,000 and a maximum raise of $1,070,000, and the funds will be used to continue development, pursue clinical projects, grow partnerships, hire core team members, acquire rights to failed drugs, and pursue biopharmaceutical companies. Bullfrog AI Holdings aims to increase the chances of success in drug development by using powerful artificial intelligence.